Immune cell cryopreservation liquid and immune cell cryopreservation method

A technology of immune cells and cryopreservation solution, which is applied in the preservation, application, and animal husbandry of human or animal bodies. It can solve problems such as allergic reactions, immune rejection, and infectious diseases, and achieve good cell vitality and change permeability. sex, the effect of meeting the needs of immune cells

Active Publication Date: 2022-02-11
杭州中赢生物医疗科技有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the fetal bovine serum in the existing cell cryopreservation solution contains a large amount of foreign proteins, which not only has the risk of infectious diseases, but also easily causes allergic reactions or immune rejection, which needs to be solved urgently

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Immune cell cryopreservation liquid and immune cell cryopreservation method
  • Immune cell cryopreservation liquid and immune cell cryopreservation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] An immune cell cryopreservation solution, the components of which include:

[0032] Dimethyl sulfoxide 0.02mg / mL,

[0033] Cucurbitacin 1mg / mL,

[0034] Acacia polysaccharide 0.01mL / mL,

[0035] Lentinan 1mg / mL,

[0036] Polyglycerol fatty acid ester 1 μg / mL,

[0037] Polyethylene glycol 0.01mg / mL,

[0038] Non-essential amino acids 10mg / mL,

[0039] Human serum albumin 12mg / mL.

[0040] A method for cryopreserving immune cells, comprising the steps of:

[0041] S1. Take peripheral blood in a centrifuge tube, centrifuge for 10 minutes, remove the upper layer of plasma, add an equal volume of PBS buffer to the lower layer of cells and mix evenly, then add Ficoll separation solution to make the layers clear, absorb the peripheral blood mononuclear cell layer after centrifugation, add PBS buffer was mixed and centrifuged to obtain peripheral blood mononuclear cells;

[0042] S2. Mix the peripheral blood mononuclear cells with the above-mentioned immune cell cryopre...

Embodiment 2

[0045] An immune cell cryopreservation solution, the components of which include:

[0046] Dimethyl sulfoxide 0.06mg / mL,

[0047] Cucurbitacin 6mg / mL,

[0048] Acacia polysaccharide 0.03mL / mL,

[0049] Lentinan 2mg / mL,

[0050] Polyglycerol fatty acid ester 5μg / mL,

[0051] Polyethylene glycol 0.03mg / mL,

[0052] Non-essential amino acids 16mg / mL,

[0053] Human serum albumin 20mg / mL.

[0054] A method for cryopreserving immune cells, comprising the steps of:

[0055] S1. Take peripheral blood in a centrifuge tube, centrifuge for 20 minutes, remove the upper layer of plasma, add an equal volume of PBS buffer to the lower layer of cells and mix evenly, then add Ficoll separation solution to make the layers clear, absorb the peripheral blood mononuclear cell layer after centrifugation, add PBS buffer was mixed and centrifuged to obtain peripheral blood mononuclear cells;

[0056] S2. Mix the peripheral blood mononuclear cells with the above-mentioned immune cell cryopres...

Embodiment 3

[0059] An immune cell cryopreservation solution, the components of which include:

[0060] Dimethyl sulfoxide 0.03mg / mL,

[0061] Cucurbitacin 5mg / mL,

[0062]Acacia polysaccharide 0.015mL / mL,

[0063] Lentinan 1.7mg / mL,

[0064] Polyglycerol fatty acid ester 2μg / mL,

[0065] Polyethylene glycol 0.025mg / mL,

[0066] Non-essential amino acids 12mg / mL,

[0067] Human serum albumin 18mg / mL.

[0068] A method for cryopreserving immune cells, comprising the steps of:

[0069] S1. Take peripheral blood in a centrifuge tube, centrifuge for 13 minutes, remove the upper layer of plasma, add an equal volume of PBS buffer to the lower layer of cells and mix evenly, then add Ficoll separation solution to make the layers clear, absorb the peripheral blood mononuclear cell layer after centrifugation, add PBS buffer was mixed and centrifuged to obtain peripheral blood mononuclear cells;

[0070] S2. Mix the peripheral blood mononuclear cells with the above-mentioned immune cell cryop...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an immune cell cryopreservation liquid, which comprises the following components: 0.02 to 0.06 mg / mL of dimethyl sulfoxide, 1 to 6 mg / mL of cucurbitacine, 0.01 to 0.03 mL / mL of gleditsia sinensis polysaccharide, 1 to 2 mg / mL of lentinan, 1 to 5 [mu]g / mL of polyglycerol fatty acid ester, 0.01 to 0.03 mg / mL of polyethylene glycol, 10 to 16 mg / mL of non-essential amino acid and 12 to 20 mg / mL of human serum albumin. The invention discloses an immune cell cryopreservation method which comprises the following steps: uniformly mixing peripheral blood mononuclear cells with the immune cell cryopreservation liquid to obtain a cell suspension, transferring the cell suspension into a sterile cryopreservation tube, then putting the cell suspension into a cryopreservation box, carrying out programmed cooling to-70 DEG C, carrying out cryopreservation for 10-15 hours, and then transferring the cell suspension into liquid nitrogen for cryopreservation, wherein the concentration of the cells in the cell suspension is (2-4) * 10<7> cells / mL.

Description

technical field [0001] The invention relates to the technical field of cell cryopreservation, in particular to an immune cell cryopreservation solution and an immune cell cryopreservation method. Background technique [0002] Biological immune cell therapy can induce autologous antiviral immune response through in vitro culture, proliferation, activation, and reinfusion into the body. Once the human antiviral immunity is activated, it will continuously produce antiviral substances to kill the virus. After activation, most of the T cells that can kill tumor cells become memory cells and store in lymphoid tissues, providing long-term protection for the complete elimination of tumor cells and the prevention and treatment of metastasis and recurrence. [0003] With the rapid development of immune cell biology and immune molecular biology, somatic cell immunotherapy has become one of the important means of adjuvant therapy after radiotherapy and chemotherapy for tumor patients. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A01N1/02
CPCA01N1/0221
Inventor 不公告发明人
Owner 杭州中赢生物医疗科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap